Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sano, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sano, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 31:571-572 (2001)
© 2001 Foundation for Promotion of Cancer Research

Editorial

Is Peritoneal Carcinomatosis an Incurable Disease or Controllable Locoregional Condition? — Challenge of Surgeons with Intraperitoneal Hyperthermic Chemotherapy

Takeshi Sano

Gastric Surgery Division, National Cancer Center Hospital, Tokyo, Japan

Peritoneal carcinomatosis is the most common terminal feature of abdominal cancers. For gastrointestinal surgeons and medical oncologists, it is a vexing condition because, although the disease is limited to the peritoneal surface, complete surgical removal is impossible and systemic chemotherapy is powerless. Peritoneal carcinomatosis is generally considered to be an untreatable condition that makes clinicians abandon further aggressive treatments.

Gynecologists have some different views on ovarian cancer. They have tried extensive debulking surgery for the peritoneal disease followed by intraperitoneal (i.p.) cisplatin-based chemotherapy. A large, randomized controlled trial has recently shown significant survival benefit of . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?